Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Schulz

Showing results (331-340 of 418) with videos related to

Pageof 42
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2022
High-Fat Diet Rapidly Modifies Trafficking, Phenotype, and Function of Plasmacytoid Dendritic Cells in Adipose TissueSusanne Stutte, Hellen Ishikawa-Ankerhold, Lydia Lynch, et al.
Journal of Pain and Symptom Management|April 29, 2026
Intranasal Ketamine for Existential Distress in Advanced CancerStefan Aguiar, Mary Makarious, Orly Lipsitz, et al.
Gut|August 9, 2022
Management of <i>Helicobacter pylori</i> infection: the Maastricht VI/Florence consensus reportPeter Malfertheiner, Francis Megraud, Theodore Rokkas, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access programNikolaj Frost, Petros Christopoulos, Diego Kauffmann-Guerrero, et al.
Science Translational Medicine|December 2, 2016
Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosisTobias Petzold, Manuela Thienel, Ildiko Konrad, et al.
Gut|November 10, 2020
Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic functionFabian Frost, Tim Kacprowski, Malte Rühlemann, et al.
Frontiers in Pharmacology|April 2, 2021
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)Daniel Heudobler, Christian Schulz, Jürgen R Fischer, et al.
Developmental Cell|June 29, 2013
Fuz mutant mice reveal shared mechanisms between ciliopathies and FGF-related syndromesJacqueline M Tabler, William B Barrell, Heather L Szabo-Rogers, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 20, 2023
Neutrophils-biology and diversityDaniela Maier-Begandt, Noelia Alonso-Gonzalez, Luisa Klotz, et al.
Gut Pathogens|July 9, 2025
Profiling of the tumor-associated microbiome in patients with hepatocellular carcinomaChristian Schulz, Ramiro Vilchez-Vargas, Elif Öcal, et al.
Pageof 42

Showing results (331-340 of 418) with videos related to

Sort By:
Pageof 42
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2022
High-Fat Diet Rapidly Modifies Trafficking, Phenotype, and Function of Plasmacytoid Dendritic Cells in Adipose TissueSusanne Stutte, Hellen Ishikawa-Ankerhold, Lydia Lynch, et al.
Journal of Pain and Symptom Management|April 29, 2026
Intranasal Ketamine for Existential Distress in Advanced CancerStefan Aguiar, Mary Makarious, Orly Lipsitz, et al.
Gut|August 9, 2022
Management of <i>Helicobacter pylori</i> infection: the Maastricht VI/Florence consensus reportPeter Malfertheiner, Francis Megraud, Theodore Rokkas, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access programNikolaj Frost, Petros Christopoulos, Diego Kauffmann-Guerrero, et al.
Science Translational Medicine|December 2, 2016
Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosisTobias Petzold, Manuela Thienel, Ildiko Konrad, et al.
Gut|November 10, 2020
Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic functionFabian Frost, Tim Kacprowski, Malte Rühlemann, et al.
Frontiers in Pharmacology|April 2, 2021
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)Daniel Heudobler, Christian Schulz, Jürgen R Fischer, et al.
Developmental Cell|June 29, 2013
Fuz mutant mice reveal shared mechanisms between ciliopathies and FGF-related syndromesJacqueline M Tabler, William B Barrell, Heather L Szabo-Rogers, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 20, 2023
Neutrophils-biology and diversityDaniela Maier-Begandt, Noelia Alonso-Gonzalez, Luisa Klotz, et al.
Gut Pathogens|July 9, 2025
Profiling of the tumor-associated microbiome in patients with hepatocellular carcinomaChristian Schulz, Ramiro Vilchez-Vargas, Elif Öcal, et al.
Pageof 42